categorieshighlightstalkshistorystories
home pageconnectwho we aresupport

Sam Altman Claims 'Superintelligence' Will Surpass AGI in Significance

December 5, 2024 - 20:13

Sam Altman Claims 'Superintelligence' Will Surpass AGI in Significance

In a recent statement, Sam Altman, the CEO of OpenAI, expressed his belief that the emergence of superintelligence will be far more impactful than artificial general intelligence (AGI). Altman suggested that we are only "a few thousand days" away from achieving this advanced form of intelligence, which he predicts will revolutionize various aspects of society.

Superintelligence, according to Altman, represents a level of cognitive capability that exceeds human intelligence in virtually every domain. He emphasized that while AGI is a significant milestone, it is the subsequent leap to superintelligence that will truly reshape industries, economies, and even the fabric of daily life.

The implications of this technology are vast, raising questions about ethics, control, and the future of human labor. As discussions around the potential risks and benefits of superintelligence continue, Altman’s remarks highlight the urgency for proactive measures in governance and regulation to ensure that this powerful technology is developed responsibly.


MORE NEWS

Risk, Resilience, And Humanity's Expanding Technological Frontiers

May 3, 2026 - 10:57

Risk, Resilience, And Humanity's Expanding Technological Frontiers

As humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...

Business Leaders Say Adapting to AI Is Essential to Survival

May 2, 2026 - 20:16

Business Leaders Say Adapting to AI Is Essential to Survival

Top executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...

A brain implant to treat depression gets FDA greenlight to start trials

May 2, 2026 - 02:14

A brain implant to treat depression gets FDA greenlight to start trials

A small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...

Enova To Present at the Needham Technology, Media, & Consumer Conference

May 1, 2026 - 12:36

Enova To Present at the Needham Technology, Media, & Consumer Conference

Enova International, a financial services company known for using machine learning and advanced analytics, has confirmed its participation in an upcoming industry event. The company announced today...

read all news
categorieshighlightstalkshistorystories

Copyright © 2026 WiredLabz.com

Founded by: Kira Sanders

home pageconnectwho we arerecommendationssupport
cookie settingsprivacyterms